MOACM
TBPH icon

Mutual of America Capital Management’s Theravance Biopharma TBPH Stock Holding History

Mutual of America Capital Management’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-79,290
Closed -$1.15M – 1665
2021
Q2 		$1.15M Sell
79,290
-3,410
-4% -$64K 0.01% 1077
2021
Q1 		$1.69M Sell
82,700
-4,585
-5% -$87.1K 0.02% 1012
2020
Q4 		$1.55M Sell
87,285
-1,844
-2% -$33.1K 0.02% 998
2020
Q3 		$1.32M Buy
+89,129
New +$1.67M 0.02% 978

Other funds holding TBPH

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Mutual of America Capital Management's TBPH Position: Q3 2021 in Review

Mutual of America Capital Management sold out of Theravance Biopharma (TBPH) in Q3 2021, closing a stake of 79,290 shares — an estimated $1.15M sold.

Mutual of America Capital Management first reported a position in TBPH in Q3 2020 and held it in 4 quarters. The position peaked at $1.69M in Q1 2021. 119 funds tracked by Wall St. Rank hold TBPH as of Q3 2021.

  • Mutual of America Capital Management reported no remaining Theravance Biopharma position as of Q3 2021 after selling out during the quarter.
  • Mutual of America Capital Management sold 79,290 Theravance Biopharma shares in Q3 2021, an estimated $1.15M.
  • Mutual of America Capital Management first reported a position in Theravance Biopharma in Q3 2020 and held it in 4 quarters.
  • Mutual of America Capital Management's Theravance Biopharma position peaked at $1.69M in Q1 2021.
  • 119 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2021.

Based on Mutual of America Capital Management's 13F filing for Q3 2021, filed 10 Nov 2021.